NEO
Neogenomics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
NEO fundamentals
Neogenomics (NEO) expects to report earnings on Jul 29, 2025, with estimated revenue of 183.03M (YoY +11.26%), and EPS at 0.03 (YoY 0.00%).
Revenue estimate / YoY
183.03M
+11.26%
EPS estimate / YoY
0.03
0.00%
Report date
Jul 29, 2025
Earnings Call
8:30 AM on Jul 29, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
NEO has released its 2025 Q1 earnings report, with revenue of 168.03M, reflecting a YoY change of 7.55%, and net profit of -25.92M, showing a YoY change of 4.21%. The Sankey diagram below clearly presents NEO's revenue sources and cost distribution.
Key Indicators
Neogenomics (NEO) key financial stats and ratios, covering profitability, financial health, and leverage.
Neogenomics (NEO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Neogenomics (NEO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Neogenomics (NEO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Neogenomics (NEO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Neogenomics (NEO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Neogenomics do and what are its main business segments?What is the market’s earnings forecast for Neogenomics next quarter?What factors drove the changes in Neogenomics’s revenue and profit?What were the key takeaways from Neogenomics’s earnings call?What guidance did Neogenomics’s management provide for the next earnings period? How were Neogenomics’s latest financial results overall?Did Neogenomics beat or miss consensus estimates last quarter?What is Neogenomics’s latest dividend and current dividend yield?